Expertise in
11
conditions

Fehmi Tabak

Istanbul, TR 
Expertise in
11
conditions
Istanbul, TR 

Overview

Fehmi Tabak practices practicing medicine in Istanbul, Turkey.

Tabak is highly rated in 11 conditions, according to our data. Their clinical expertise encompasses Hepatitis B, Hepatitis, Febrile Neutropenia, and Hepatitis D.

They are actively involved in clinical research, co-authoring 136 peer reviewed articles and participating in 2 clinical trials.

Locations

Istanbul, Turkey
Other Locations
Cerrahpasa, Turkey
Ankara, Turkey
Gaziosmanpasa, Turkey
Fatih, 34098, Turkey
Beylerbeyi, 81210, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Phase 3, Randomized, Open-Label, Parallel Arm Study to Evaluate the Efficacy and Safety of 180 mcg Peginterferon Lambda-1a (Lambda) Subcutaneous Injection for 48 Weeks in Patients With Chronic Hepatitis Delta Virus (HDV) Infection (LIMT-2)
Enrollment Status: Unknown
Publish Date: August 25, 2023
Intervention Type: Drug
Study Drug: Peginterferon Lambda-1a
Study Phase: Phase 3
Evaluation of Efficacy and Safety of Direct Acting Agents in Hepatitis C Patients
Evaluation of Efficacy and Safety of Direct Acting Agents in Hepatitis C Patients
Enrollment Status: Completed
Publish Date: October 01, 2019
View 1 Less Clinical Trial

136 Total Publications

Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye.
Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: April 27, 2026

Frequently Asked Questions about Fehmi Tabak

Is Fehmi Tabak a top-rated expert for Hepatitis B?

MediFind is an objective health platform that identifies experts based on real-world data. Fehmi Tabak is classified as an Elite expert for Hepatitis B, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fehmi Tabak participate in research or clinical trials?

Yes. Fehmi Tabak has published 136 articles and abstracts on conditions like Hepatitis B. You can view a list of Fehmi Tabak's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tabak's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile